Skip to content

QUIXX® acute

by Aurena Laboratories AB EUDAMED

Active European Union

Ref 301362Model REF 2018

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number28620131862-04 Date10 Jun 2026IssuedStatusActive expires 27 Oct 2027

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)

Specification

EUDAMED

Device Name
Aurena Nasal Spray, Hypertonic
Model / Reference
REF 2018, 301362
Primary DI / UDI-DI
07332343300305
Basic UDI-DI
7332343200127J
Direct Marketing DI
07332343300305
EMDN Code
Q030103 Nasal irrigation solutions
Device Class
Class IIa
Market of Registration
Bulgaria

Manufacturer details

EUDAMED SRN
SE-MF-000002890

Other devices from Aurena Laboratories AB

See all devices from Aurena Laboratories AB →

Properties

Show properties
  • Sterile
Other properties (12)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No